Trevi Therapeutics Inc (NASDAQ: TRVI) kicked off on November 20, 2023, at the price of $1.41, down -6.47% from the previous trading day. During the day, the shares moved up to $1.41 and dropped to $1.28 before settling in for the closing price of $1.39. Over the past 52 weeks, TRVI has traded in a range of $1.15-$3.50.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
While this was happening, its average annual earnings per share was recorded 31.85%. With a float of $41.30 million, this company’s outstanding shares have now reached $59.94 million.
The firm has a total of 25 workers. Let’s measure their productivity.
Trevi Therapeutics Inc (TRVI) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Trevi Therapeutics Inc is 35.33%, while institutional ownership is 46.05%. The most recent insider transaction that took place on Oct 11, was worth 1,586. In this transaction Chief Financial Officer of this company sold 785 shares at a rate of $2.02, taking the stock ownership to the 35,901 shares. Before that another transaction happened on Sep 11, when Company’s Chief Financial Officer sold 711 for $2.20, making the entire transaction worth $1,564. This insider now owns 34,394 shares in total.
Trevi Therapeutics Inc (TRVI) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported -$0.08 earnings per share (EPS), higher than consensus estimate (set at -$0.09) by $0.01. This company achieved a return on equity of -46.82. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.85% per share during the next fiscal year.
Trevi Therapeutics Inc (NASDAQ: TRVI) Trading Performance Indicators
Take a look at Trevi Therapeutics Inc’s (TRVI) current performance indicators. Last quarter, stock had a quick ratio of 18.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.27, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Trevi Therapeutics Inc (TRVI)
Analysing the last 5-days average volume posted by the [Trevi Therapeutics Inc, TRVI], we can find that recorded value of 0.4 million was better than the volume posted last year of 0.17 million. As of the previous 9 days, the stock’s Stochastic %D was 52.03%. Additionally, its Average True Range was 0.15.
During the past 100 days, Trevi Therapeutics Inc’s (TRVI) raw stochastic average was set at 11.28%, which indicates a significant decrease from 21.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.33% in the past 14 days, which was higher than the 58.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8569, while its 200-day Moving Average is $2.2262. Now, the first resistance to watch is $1.3800. This is followed by the second major resistance level at $1.4600. The third major resistance level sits at $1.5100. If the price goes on to break the first support level at $1.2500, it is likely to go to the next support level at $1.2000. Should the price break the second support level, the third support level stands at $1.1200.
Trevi Therapeutics Inc (NASDAQ: TRVI) Key Stats
The company with the Market Capitalisation of 83.02 million has total of 63,858K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -29,150 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -7,700 K.